Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 61 pharmaceuticals ranked by net assets, at TRY 4.36T, ahead of Johnson & Johnson (TRY 4.11T) and Sanofi (TRY 3.99T). Figures as of 18 Nov 2026, 14:31 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- PfizerTRY 4.36T
- Median
- TRY 44.3B
- Combined market value
- TRY 258.05T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | TRY 4.36T | TRY 8.13T | TRY 1,425.99 | 0.66% down | 14% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | TRY 4.11T | TRY 33.52T | TRY 13,922.90 | 1.00% down | 38% up | ||
| 3 | SanofiSNY · Health Care | TRY 3.99T | TRY 5.73T | TRY 2,386.06 | 0.47% down | 4% down | ||
| 4 | Merck & CoMRK · Health Care | TRY 2.65T | TRY 17.57T | TRY 7,129.03 | 1.44% down | 51% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | TRY 2.63T | TRY 9.15T | TRY 5,281.46 | 2.55% down | 17% down | ||
| 6 | AstraZenecaAZN · Health Care | TRY 2.45T | TRY 14.07T | TRY 9,072.95 | 1.28% down | 2% up | ||
| 7 | Takeda PharmaceuticalTAK · Health Care | TRY 2.35T | TRY 3.46T | TRY 1,082.42 | 0.85% down | 54% up | ||
| 8 | NovartisNVS · Health Care | TRY 2.33T | TRY 14.95T | TRY 7,917.90 | 1.37% down | 25% up | ||
| 9 | Regeneron PharmaceuticalsREGN · Health Care | TRY 1.58T | TRY 4.97T | TRY 48,024.39 | 0.59% down | 36% up | ||
| 10 | Novo NordiskNVO · Health Care | TRY 1.45T | TRY 8.93T | TRY 2,025.12 | 1.36% down | 17% down | ||
| 11 | Eli LillyLLY · Health Care | TRY 1.34T | TRY 63.21T | TRY 70,964.51 | 0.60% down | 35% up | ||
| 12 | GSKGSK · Health Care | TRY 1.1T | TRY 4.95T | TRY 2,467.47 | 0.62% down | 6% up | ||
| 13 | Vertex PharmaceuticalsVRTX · Health Care | TRY 941.5B | TRY 6.8T | TRY 26,818.62 | 0.47% down | 27% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | TRY 931.8B | TRY 6.26T | TRY 3,063.66 | 1.04% down | 34% up | ||
| 15 | ViatrisVTRS · Health Care | TRY 742B | TRY 1.19T | TRY 1,034.00 | 0.24% up | 96% up | ||
| 16 | Royalty PharmaRPRX · Health Care | TRY 490B | TRY 1.98T | TRY 3,451.28 | 0.37% down | 78% up | ||
| 17 | Teva Pharmaceutical IndustriesTEVA · Health Care | TRY 399B | TRY 2.52T | TRY 2,162.57 | 0.62% up | 74% up | ||
| 18 | United TherapeuticsUTHR · Health Care | TRY 357.9B | TRY 1.25T | TRY 29,342.58 | 0.40% down | 23% up | ||
| 19 | Elanco Animal HealthELAN · Health Care | TRY 330.2B | TRY 650.7B | TRY 1,301.83 | 0.15% down | 20% up | ||
| 20 | BioMarin PharmaceuticalBMRN · Health Care | TRY 307B | TRY 569.5B | TRY 2,940.08 | 0.38% down | 11% up | ||
| 21 | GrifolsGRFS · Health Care | TRY 295B | TRY 294.2B | TRY 432.26 | 0.70% down | 1% up | ||
| 22 | GenmabGMAB · Health Care | TRY 294.9B | TRY 1.6T | TRY 2,601.13 | 0.75% down | 70% up | ||
| 23 | Roivant SciencesROIV · Health Care | TRY 228.4B | TRY 1.41T | TRY 1,948.96 | 0.18% down | 90% up | ||
| 24 | BeOne MedicinesONC · Health Care | TRY 220B | TRY 2.34T | TRY 20,517.71 | 1.57% down | 17% up | ||
| 25 | Jazz PharmaceuticalsJAZZ · Health Care | TRY 217.8B | TRY 777.4B | TRY 12,110.38 | 0.25% down | 37% up | ||
| 26 | Dr. Reddy's LaboratoriesRDY · Health Care | TRY 202.4B | TRY 621.1B | TRY 744.98 | 0.20% down | 5% up | ||
| 27 | ZoetisZTS · Health Care | TRY 168B | TRY 1.69T | TRY 4,154.40 | 1.34% down | 29% down | ||
| 28 | AlkermesALKS · Health Care | TRY 91.8B | TRY 386.6B | TRY 2,300.52 | 0.35% up | 58% up | ||
| 29 | Ligand PharmaceuticalsLGND · Health Care | TRY 51.3B | TRY 298.9B | TRY 14,943.53 | 0.84% up | 43% up | ||
| 30 | Legend BiotechLEGN · Health Care | TRY 50.5B | TRY 158B | TRY 814.59 | 0.25% up | 42% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | TRY 44.3B | TRY 429.4B | TRY 15,362.68 | 0.16% down | 61% up | ||
| 32 | Alnylam PharmaceuticalsALNY · Health Care | TRY 39.8B | TRY 1.05T | TRY 7,845.77 | 0.61% down | 66% down | ||
| 33 | Belite BioBLTE · Health Care | TRY 38.9B | TRY 323.1B | TRY 7,955.22 | 0.00% | 31% up | ||
| 34 | InsmedINSM · Health Care | TRY 37.3B | TRY 1.34T | TRY 6,103.11 | 0.71% down | 40% down | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | TRY 36.1B | TRY 451.2B | TRY 4,750.84 | 0.41% up | 286% up | ||
| 36 | Summit TherapeuticsSMMT · Health Care | TRY 33.2B | TRY 419.3B | TRY 524.31 | 2.58% down | 36% down | ||
| 37 | TG TherapeuticsTGTX · Health Care | TRY 32.7B | TRY 476.1B | TRY 3,149.91 | 0.41% down | 107% up | ||
| 38 | Corcept TherapeuticsCORT · Health Care | TRY 32.7B | TRY 390.7B | TRY 3,570.32 | 1.02% up | 8% down | ||
| 39 | Cogent BiosciencesCOGT · Health Care | TRY 32.1B | TRY 246.9B | TRY 1,418.85 | 1.01% up | 20% down | ||
| 40 | Protagonist TherapeuticsPTGX · Health Care | TRY 31B | TRY 410B | TRY 6,281.66 | 0.10% down | 46% up | ||
| 41 | Madrigal PharmaceuticalsMDGL · Health Care | TRY 30.4B | TRY 493.4B | TRY 21,241.08 | 0.20% down | 24% down | ||
| 42 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | TRY 28.6B | TRY 375.5B | TRY 4,779.34 | 0.37% down | 126% up | ||
| 43 | Edgewise TherapeuticsEWTX · Health Care | TRY 26.3B | TRY 233.6B | TRY 2,133.57 | 0.62% up | 88% up | ||
| 44 | ABIVAXABVX · Health Care | TRY 25.5B | TRY 366.5B | TRY 4,186.43 | 1.10% up | 27% down | ||
| 45 | Dianthus TherapeuticsDNTH · Health Care | TRY 24.9B | TRY 241.7B | TRY 4,291.85 | 2.17% down | 113% up | ||
| 46 | Ionis PharmaceuticalsIONS · Health Care | TRY 24.7B | TRY 224.8B | TRY 1,349.49 | 0.76% down | 64% down | ||
| 47 | Oruka TherapeuticsORKA · Health Care | TRY 23.8B | TRY 328.1B | TRY 4,838.10 | 0.42% down | 241% up | ||
| 48 | Arrowhead PharmaceuticalsARWR · Health Care | TRY 23.5B | TRY 305B | TRY 2,157.78 | 0.49% down | 10% up | ||
| 49 | Definium TherapeuticsDFTX · Health Care | TRY 16.8B | TRY 201.6B | TRY 1,472.82 | 0.61% down | 169% up | ||
| 50 | ErascaERAS · Health Care | TRY 16.4B | TRY 247.1B | TRY 704.13 | 0.50% up | 403% up | ||
| 51 | Mirum PharmaceuticalsMIRM · Health Care | TRY 15.9B | TRY 301.4B | TRY 4,616.67 | 0.46% down | 31% up | ||
| 52 | Rhythm PharmaceuticalsRYTM · Health Care | TRY 7B | TRY 404.7B | TRY 5,836.79 | 0.76% down | 13% up | ||
| 53 | Travere TherapeuticsTVTX · Health Care | TRY 5.8B | TRY 245.2B | TRY 2,554.48 | 0.89% down | 44% up | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | TRY 4.5B | TRY 362.1B | TRY 6,884.91 | 0.40% up | 7% down | ||
| 55 | Amneal PharmaceuticalsAMRX · Health Care | -TRY 3.6B | TRY 371.2B | TRY 1,065.27 | 0.00% | 83% up | ||
| 56 | VeradermicsMANE · Health Care | -TRY 6.1B | TRY 269.2B | TRY 6,378.76 | 0.46% up | 233% up | ||
| 57 | Ascendis PharmaASND · Health Care | -TRY 9.1B | TRY 888.2B | TRY 13,541.08 | 1.00% down | 28% up | ||
| 58 | PTC TherapeuticsPTCT · Health Care | -TRY 10.4B | TRY 252.2B | TRY 3,019.27 | 0.83% down | 20% down | ||
| 59 | CytokineticsCYTK · Health Care | -TRY 33.3B | TRY 364.7B | TRY 2,617.78 | 0.48% up | 20% down | ||
| 60 | BridgeBio PharmaBBIO · Health Care | -TRY 105.2B | TRY 751.7B | TRY 3,858.58 | 0.39% down | 17% up | ||
| 61 | AbbVieABBV · Health Care | -TRY 164.9B | TRY 25.85T | TRY 14,622.24 | 1.01% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4389 TRY).
Questions and answers
Which pharmaceuticals rank first by net assets?
Pfizer (TRY 4.36T), Johnson & Johnson (TRY 4.11T) and Sanofi (TRY 3.99T) are the top three of the 61 pharmaceuticals ranked by net assets as of 18 Nov 2026, 14:31 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of TRY 258.05T as of 18 Nov 2026, 14:31 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.